The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126771971 12677197 1 I 20130424 20160815 20160823 20160823 EXP CA-ALEXION PHARMACEUTICALS INC-A201606093 ALEXION 9.46 YR F Y 54.40000 KG 20160823 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126771971 12677197 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, QW 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
126771971 12677197 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, Q2W 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
126771971 12677197 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
126771971 12677197 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q3W 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION Q3W
126771971 12677197 5 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q3W 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION Q3W
126771971 12677197 6 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q31DAYS 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION
126771971 12677197 7 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q3W 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION Q3W
126771971 12677197 8 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q2W AE7317B04 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
126771971 12677197 9 C AMOXICILLINE /00249602/ AMOXICILLIN 1 Oral 250 MG, BID 0 250 MG BID
126771971 12677197 10 C NORVASC AMLODIPINE BESYLATE 1 Oral 2.5 MG, QHS 0 2.5 MG QD
126771971 12677197 11 C NORVASC AMLODIPINE BESYLATE 1 Oral 5 MG, QD (AM) 0 5 MG QD
126771971 12677197 12 C MINIPRESS PRAZOSIN HYDROCHLORIDE 1 Oral 1 MG, BID 0 1 MG BID
126771971 12677197 13 C LOSARTAN. LOSARTAN 1 Oral 37.5 MG, BID 0 37.5 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126771971 12677197 1 Haemolytic uraemic syndrome
126771971 12677197 9 Prophylaxis
126771971 12677197 10 Hypertension
126771971 12677197 12 Hypertension
126771971 12677197 13 Hypertension

Outcome of event

Event ID CASEID OUTC COD
126771971 12677197 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126771971 12677197 Dehydration
126771971 12677197 Gastroenteritis
126771971 12677197 Inappropriate schedule of drug administration

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126771971 12677197 1 20091008 20091022 0
126771971 12677197 2 20091105 20120416 0
126771971 12677197 3 20120430 20130403 0
126771971 12677197 4 20130424 20130626 0
126771971 12677197 5 20130717 20140129 0
126771971 12677197 6 20140220 20140609 0
126771971 12677197 7 20140630 20141117 0
126771971 12677197 8 20141203 0
126771971 12677197 9 20040601 0
126771971 12677197 10 20040601 0
126771971 12677197 11 20040601 0
126771971 12677197 12 20040601 0
126771971 12677197 13 20040601 0